22. Moyamoya disease Clinical trials / Disease details
Clinical trials : 14 / Drugs : 21 - (DrugBank : 14) / Drug target genes : 28 - Drug target pathways : 44
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02510586 (ClinicalTrials.gov) | August 2015 | 24/7/2015 | Sevoflurane and Hyperperfusion Syndrome | Effect of Sevoflurane-induced Postconditioning on the Incidence of Postoperative Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Adult Patients With Moyamoya Disease | Hyperperfusion Syndrome;Moyamoya Disease | Drug: Sevoflurane | Seoul National University Hospital | NULL | Not yet recruiting | 18 Years | N/A | Both | 152 | N/A | NULL |